Collection of Biospecimen and Clinical Information in Patients With Gastrointestinal Cancers

Stanford University1 site in 1 countryJanuary 2010

ConditionsGastrointestinal Neoplasms Gynecologic Cancers Gynecologic Cancers Cervical Cancer Gastric (Stomach) Cancer Gastro-Esophageal(GE) Junction Cancer Gastrointenstinal Stromal Tumor (GIST)Colon/Rectal Cancer Colon/Rectal Cancer Colon Cancer Colon/Rectal Cancer Rectal Cancer Colon/Rectal Cancer Anal Cancer Anal Cancer Hepatobiliary Cancers Hepatobiliary Cancers Liver Pancreatic Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Gastrointestinal Neoplasms
Sponsor: Stanford University
Locations: 1
Primary Endpoint: None: Biospecimen will be collected for future research.
Status: Withdrawn
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers.

PRIMARY OBJECTIVES:

To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers.

SECONDARY OBJECTIVES:

Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories
Collect details about the tumor specimen extracted from patient charts.

Registry

clinicaltrials.gov

Start Date

January 2010

End Date

January 2099

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Stanford University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients are eligible if they have a histologically proven gastrointestinal cancer (esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor).
•18 years of age or older
•Ability to understand and the willingness to sign a written informed consent document.